RxDoctor Payments Data

Kyrollis Attalla, MD

Urology · New York, NYNPI 1912326174

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $351,133 of the $380,988 with a category attached, or 92.2%. EDAP Technomed Inc accounts for 92.9% of it on its own, with 28 other manufacturers making up the rest. 2025 is the largest year on record at $231,112, more than ten times the $22 reported in 2019. Among urology clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$380,988in general payments, 2019–2025

Across 330 payments — averaging $1154.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • EDAP Technomed Inc$354K
  • Koelis Inc.$24K
  • Profound Medical Corp.$625
  • Pfizer$426
  • Endo USA, Inc.$253
  • Progenics Pharmaceuticals, Inc.$221
  • plus $2K from 23 others

What the payments were for

  • Consulting fees$351,13392%
  • Speaking & faculty fees$6,1252%
  • Travel & lodging$8,8452%
  • Food & beverage$14,0904%
  • Education$5920%
  • Entertainment$2030%

General payments by program year

19
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$380,988 in reported general payments places this provider in the 95th percentile of 952 urology providers in New York.

See all urology providers in New York

Medicare billing

Part B allowed, 2024
$116,298
Medicare patients
257
Services billed
709

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Tamsulosin Hcl402$2,422
Finasteride114$1,322
Oxybutynin Chloride ErOxybutynin Chloride17$497

Paid to pharmacies, not to this prescriber.

Other urology in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →